Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment is no longer looking for participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T14:41:40.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 has been added to the record history, and the previous v3.5.4 entry has been removed from the list. This updates the version trail for the study record to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-06-05T09:55:08.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the study's version history, and the previous revision (v3.5.3) was removed from the list.
    Difference
    0.1%
    Check dated 2026-05-15T06:14:38.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s displayed software revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor update to the ClinicalTrials.gov interface rather than a change to any trial record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:00:34.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:01.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a new revision (v3.5.0) to the Record History, replacing the previous v3.4.3 entry to reflect an updated study record.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:56.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.